Q2 2024 Holdings
Filed 2024-08-14 | 38 holdings | $1.9B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-08-20) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vanguard Index FDS(VTI)A | TOTAL STK MKT | 922908769 | $277.8M | 1,038,550 | 15.0% |
| Brookfield Corp(BN) | CL A LTD VT SH | 11271J107 | $161.2M | 3,880,230 | 8.7% |
| Tempus AI Inc(TEM) | CL A | 88023B103 | $142.6M | 4,074,419 | 7.7% |
| Asml Holding N V(ASML) | N Y REGISTRY SHS | N07059210 | $136.4M | 133,336 | 7.4% |
| Salesforce Inc(CRM) | COM | 79466L302 | $123.4M | 480,160 | 6.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $114.3M | 6,344,430 | 6.2% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $78.3M | 2,411,362 | 4.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $71.7M | 950,000 | 3.9% |
| Evotec AG(EVO) | SPONSORED ADS | 30050E105 | $71.2M | 14,829,842 | 4.1% |
| Exscientia PLC | ADS | 30223G102 | $66.7M | 13,086,600 | 3.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $53.6M | 800,000 | 2.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $51.3M | 1,500,000 | 2.8% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $44.8M | 1,000,000 | 2.4% |
| Cable One Inc(CABO) | COM | 12685J105 | $41.9M | 118,403 | 2.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $40.3M | 490,000 | 2.2% |
| Merus N V | COM | N5749R100 | $39.9M | 675,000 | 2.2% |
| Apple Inc(AAPL) | COM | 037833100 | $38.5M | 182,960 | 2.1% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $36.1M | 500,827 | 1.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $32.4M | 1,725,000 | 1.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $31.5M | 850,000 | 1.7% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $29.4M | 1,400,000 | 1.6% |
| Lanzatech Global Inc | COM | 51655R101 | $29.3M | 15,814,845 | 1.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $28.8M | 118,383 | 1.6% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $27.8M | 1,500,000 | 1.5% |
| Viridian Therapeutics Inc(VRDN)A | COM | 92790C104 | $26.0M | 2,000,000 | 1.4% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $25.4M | 1,544,000 | 1.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $24.8M | 2,500,000 | 1.3% |
| Brookfield Asset Managmt LTD(BAM) | CL A LMT VTG SHS | 113004105 | $23.9M | 627,207 | 1.3% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $23.7M | 1,100,000 | 1.3% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $23.3M | 1,450,500 | 1.3% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $18.9M | 175,000 | 1.0% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $13.1M | 1,750,000 | 0.7% |
| Morphic Hldg Inc | COM | 61775R105 | $12.8M | 375,000 | 0.7% |
| Verve Therapeutics Inc | COM | 92539P101 | $11.7M | 2,400,000 | 0.6% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $7.3M | 1,800,000 | 0.4% |
| IO Biotech Inc(IOBT) | COM | 449778109 | $5.2M | 4,429,449 | 0.3% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $3.3M | 1,126,915 | 0.2% |
| Marqeta Inc(MQ)A | CLASS A COM | 57142B104 | $2.4M | 441,558 | 0.1% |
| Galecto Inc(GLTOUSD) | COM | 36322Q107 | $1.2M | 2,497,791 | 0.1% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $609.6K | 468,902 | 0.0% |